INBS

INBS

USD

Intelligent Bio Solutions Inc. Common Stock

$1.290-0.020 (-1.527%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.310

Hoch

$1.310

Tief

$1.270

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

8.8M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.21M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1Aktuell $1.290Hoch $3.04

Ähnliche Nachrichten

GlobeNewswire

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today

Mehr anzeigen
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
GlobeNewswire

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing

Mehr anzeigen
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
GlobeNewswire

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned entry into

Mehr anzeigen
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
GlobeNewswire

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today

Mehr anzeigen
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.